Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.

Cabagnols, X., Defour, J.-P., Ugo, V., Ianotto, J. C., Mossuz, P., Mondet, J., Girodon, F., Alexandre, J. H., Mansier, O., Viallard, J. F., Lippert, E., Murati, A., Mozziconacci, M. J., Saussoy, P., Vekemans, M.-C., Knoops, L., Pasquier, F., Ribrag, V., Solary, E., et al. (2015). Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution. Leukemia, 29(1), 249-252. https://doi.org/10.1038/leu.2014.270 (Original work published 2015)